Influenza pandemics of the 20th century

Emerging Infectious Diseases

Volumn 12, Issue 1, 2006, Pages 9-14

  Kilbourne, Edwin D ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b New York Medical College ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ANTIBODY RESPONSE; ANTIGENIC VARIATION; ASIA; BACTERIAL INFECTION; HONG KONG; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFLUENZA VIRUS A; NONHUMAN; REVIEW; VIRUS PNEUMONIA; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; WORLD HEALTH ORGANIZATION;

EID: 31344448218     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1201.051254     Document Type: Review

References (29)

1. Taubenberger JK, Morens DM. 1918 influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12:15-22.
2. Shope RE. The influenza viruses of swine and man. Harvey Lect. 1935-1936:30:183-213.
3. Chun JWH. Influenza, including its infection among pigs. National Medical Journal of China. 1919;5:34-44.
4. Kilbourne ED. The severity of influenza as a reciprocal of host susceptibility. In: Ciba Foundation Study Group, No. 4. Virus virulence and pathogenicity. Boston: Little, Brown and Co., 1960. p. 55-77.
5. Smith W, Andrewes CH, Laidlaw PP. A virus obtained from influenza patients. Lancet. 1933;2:66-8.
6. Rogers DE, Louria DB, Kilbourne ED. The syndrome of fatal influenza virus pneumonia. Trans Assoc Am Physicians. 1958;71:260-73.
7. Langmuir AD. Epidemiology of Asian influenza, international conference on Asian influenza. Am Rev Respir Dis. 1961;83:2-14.
8. Hong Kong battling influenza epidemic. New York Times. 1957 Apr 17; 3.
9. Choppin PW, Tamm I. Studies of two kinds of virus particles which comprise influenza A2 virus strains. II. Reactivity with virus inhibitors in normal sera. J Exp Med. 1960;112:921-44.
10. Kilbourne ED. Studies on influenza in the pandemic of 1957-58. III. Isolation of influenza A (Asian strain) viruses from influenza patients with pulmonary complications. Details of virus isolation and characterization of isolates, with quantitative comparison of isolation methods. J Clin Invest. 1959;38:266-74.
11. Louria DD, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-58. II. Pulmonary complications of influenza. J Clin Invest. 1959;38:213-65.
12. Meiklejohn G. International conference on Asian influenza. Am Rev Respir Dis. 1961;83:175-7.
13. McCarroll JR, Kilbourne ED. Immunization with Asian-strain influenza vaccine: equivalence of the subcutaneous and intradermal routes. N Engl J Med. 1958;259:618-21.
14. Hayslett J, McCarroll JR, Brady E, Deuschle K, McDermott W, Kilbourne ED. Endemic influenza. I. Serologic evidence of continuing and sub-clinical infection in disparate populations in the post-pandemic period. Am Rev Resp Dis. 1962; 85:1-8.
15. Kaye D, Rosenbluth M, Hook E, Kilbourne ED. Endemic influenza. II. The nature of the disease in the post-pandemic period. Am Rev Resp Dis. 1962;85:9-21.
16. Schulman JL, Kilbourne ED. Independent variation in nature of the hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of the hemagglutinin antigen of Hong Kong-68 virus. Proc Natl Acad Sci U S A. 1969;63:326-33.
17. Stuart-Harris C. Epidemiology of influenza in man. Br Med Bull. 1979;35:3-8.
18. Monto AS, Kendal AP. Effect of neuraminidase antibody on Hong Kong influenza. Lancet. 1973;1:623-5.
19. Viboud C, Grais RF, Lafont BA, Miller MA, Simonsen L; Multinational Influenza Seasonal Morbidity Study Group. Multinational impact of the 1968 Hong Kong pandemic: evidence for a smoldering pandemic. J Infect Dis. 2005;192:223-48.
20. Eickhoff TC, Meiklejohn G. Protection against Hong Kong influenza by adjuvant vaccine containing A2-Ann Arbor-67. Bull World Health Organ. 1969;41:562-3.
21. Kilbourne ED. Influenza. New York: Plenum; 1987. p. 234.
22. Salk JE, Suriano PC. Importance of antigenic composition of influenza virus vaccine in protecting against the natural disease. Am J Public Health. 1949;39:345-55.
23. Kilbourne ED, Loge, JP, Influenza A prime: a clinical study of an epidemic caused by a new strain of virus. Ann Intern Med. 1950;33:371-79.
24. Kilbourne ED, Smith C, Brett I, Pokorny BA, Johansson B, Cox N. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc Natl Acad Sci U S A. 2002;99:10748-52.
25. Kilbourne ED. The predictable natural disaster [op. ed.]. New York Times. 1976 Apr 13; 33.
26. Beveridge WIB. Where did red flu come from? New Scientist. 1978;23:790-1.
27. Kilbourne ED. Influenza pandemics: can we predict the unpredictable? Viral Immunol. 2004;17:350-7.
28. Kilbourne ED. Future influenza vaccines and the use of genetic recombinants. Bull World Health Organ. 1969;41:643-5.
29. Chen H, Subbarao K, Swayne, D, Chen Q, Xiuhua L, Katz J, et al. Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate. Vaccine. 2003;21:1974-9.